Follicular oocytes from Xenopus laevis contain K+ channels activated by members of the recently recognized class of vasorelaxants that include cromakalim and pinacidil and blocked by antidiabetic sulfonylureas, such as glibenclamide. These channels are situated on the adherent follicular cells and are not present in denuded oocytes. Cromakalim-activated K+ channels are also activated by increases in intracellular cAMP, and cAMP-activated K+ channels are blocked by glibenclamide. Although cromakalim and cAMP effects are synergistic, cromakalim activation of K+ channels is drastically reduced or abolished by treatments that stimulate protein kinase C (e.g., muscarinic effectors, phorbol esters). Gonadotropins, known to play an essential role in ovarian physiology, also activate cromakalim and sulfonylureasensitive K+ channels. Follicular oocytes constitute an excellent system for studying regulation of cromakalim-sensitive K+ channels that are important in relation to a variety of disease processes, such as cardiovascular dysfunction and asthma, as well as brain function.
Potassium channels are involved in a wide variety of biological functions (1). Therefore, it is not surprising that their pharmacology has attracted considerable interest in the past few years (2-4), which has led to the recent development of K+ channel effectors of considerable importance for present and future therapeutic use. Two classes of such agents are antidiabetic sulfonylureas, which block ATP-sensitive K+ (KATP) channels in beta pancreatic cells (3-6) and provoke insulin release (6, 7) , and K+ channel openers (KCOs), which hyperpolarize smooth muscle cells (3, 4, [8] [9] [10] [11] [12] and have important potential applications in a variety of diseases (3, 4, 8, 13) , including hypertension and asthma. The relaxant effects of KCOs are antagonized by sulfonylureas (3, 4, 8, 12) , and both families of drugs have the same target channel (3, 4, 8, 12, 14) .
Potassium channels sensitive to both KCOs and to sulfonylureas are also present in the brain (15, 16) , where they play diverse important functions (16) , including key roles in glucose-regulated neurosecretion and in disorders associated with anoxia and ischemia (16, 17) . KCOs have been found to have antiepileptic effects (18, 19) as well.
In follicle-enclosed oocytes from Xenopus laevis, endogeneous K+ channels have been demonstrated (20) . This system provides a valuable model for investigating K+ channel regulation because K+ channel activity in follicular oocytes is modulated by cAMP, by protein kinase C-dependent processes, and by a large variety of hormones and transmitters, such as catecholamines, adenosine, gonadotropins, vasoactive intestinal peptide, the E series of prostaglandins, atrial natriuretic factor, and muscarinic agonists (20) (21) (22) (23) (24) .
This paper shows that follicular oocytes from X. laevis have a K+ channel that is activated by smooth muscle cell KCOs and blocked by antidiabetic sulfonylureas. Moreover, this channel is modulated both by protein kinase C and by variations in intracellular cAMP.
MATERIALS AND METHODS
Clusters of oocytes were removed surgically from adult X. laevis females under tricaine anesthesia and were stored in Barth saline solution [88 mM NaCl/1 mM KCI/0.82 mM MgSO4/0.33 mM Ca(NO3)2/0.41 mM CaCl2/2.4 mM NaHCO3/10 mM Hepes, pH 7.4 with NaOH] supplemented with penicillin at 100 international units per ml and streptomycin at 100 jug/ml. Oocytes were defolliculated manually in a glass Petri dish in Barth medium (24) . Oocyte diameters were measured in at least two directions (at 900) in case they were not strictly spherical. Oocytes were impaled with two glass microelectrodes filled with 3 M KCl (0.5-to 2.0-Mfl resistance) and were voltage-clamped using the Dagan 8500 voltage clamp amplifier. Voltage commands were generated using PCLAMP 
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The Ck-induced hyperpolarization is associated with the generation of a slow outward current (Fig. 1B) . This current is reversibly blocked by glibenclamide, and it is also blocked by Cs2", Ba2+, tetraethylammonium, and 4-aminopyridine, which are also known to inhibit glibenclamide-sensitive K+ channels (4, 12). It is unaffected by toxins such as apamin (1 ,uAM), dendrotoxin I (1 AuM), or charybdotoxin (1 ,uM), which are blockers of other types of Ca2+-dependent and voltagedependent K+ channels (2) but are without effect on glibenclamide-sensitive K+ channels (4, 12). The outward current elicited by Ck was reversed (Fig. 1B) when the external K+ concentration was raised to 50 mM, also suggesting that the Ck-induced current is a K+ current.
The current-voltage relationship ofthe Ck-induced current is presented in Fig. 1C . Current reversal is observed at -92 ± 3 mV (n = 7, N = 2), which is the expected reversal potential for a K+ current, thus confirming that the Ckinduced current is carried by K+ ions.
Besides Ck, there now exists a whole variety of other interesting vascular KCOs (3, 4, 8, 25), including pinacidil, nicorandil, RP61419, and minoxidil sulfate. The comparative activity of some of these different types of compounds on K+ channels in follicle-enclosed oocytes is presented in Fig. 1D (Fig. 2A) . Developmental properties of the Ck-induced response are paralleled by developmental changes in the K+ response induced in follicular oocytes by cAMP injection or by gonadotropins (20, 21, 24) . The K+ response produced by intraoocyte cAMP injection or by the various hormones that increase cAMP is known to be abolished in defolliculated oocytes (24) , indicating that cAMPactivated K+ currents arise in follicular cells and can be monitored within the oocyte through electrical coupling by gap junctions (20, 24) . A comparison of outward K+ currents elicited by cAMP, human chorionic gonadotropin (hCG), and Ck in the same follicle-enclosed oocyte at stage V is presented in Fig. 2B . Both the Ck activation and K+ channel responses produced by cAMP and hCG are abolished in defolliculated oocytes (n = 9, N = 2) (Fig. 2C) (Fig. 2D) .
The concentration-dependence of the inhibition of the Ck-induced K+ current by glibenclamide is presented in 3B. Half-maximal inhibition is observed at 200 nM glibenclamide. Other antidiabetic sulfonylureas also depress the Ck response. Glipizide is as potent as glibenclamide. However, tolbutamide, which must be used in higher therapeutic concentrations and is known to be much less active on KATP channels in beta-pancreatic cells (5), does not inhibit Ck effects at 10 ,M and is only a partial inhibitor (-40%) at concentrations as high as 100,uM (data not shown). (Fig. 3B) .
Consequently, dose-response curves for glibenclamide inhibition are very similar for Ck-activated and cAMP-activated K+ channels. Glibenclamide also potently inhibited the K+ current induced by forskolin (which directly activates adenyl cyclase), or by hCG (Fig. 3C ). These observations suggest that there are at least two classes of K+ currents activated by cAMP in follicular oocytes and that one of them, which constitutes most of the cAMP-dependent response, corresponds to glibenclamidesensitive K+ channels.
At this stage it seemed important to analyze the sensitivity of the Ck-sensitive K+ channel to cAMP. Fig. 4 shows that the Ck response is greatly potentiated when oocytes have been submitted to treatments that increase their intracellular cAMP concentration. For example, 3-isobutyl-1-methylxanthine, a phosphodiesterase inhibitor that inhibits cAMP degradation (Fig. 4B) , and low concentrations offorskolin, which activates adenyl cyclase (Fig. 4D) , increase intracellular cAMP but not to a point at which one can detect significant IcAMP values. However, this cAMP increase is high enough to provoke an important potentiation of the Ck effect. The potentiation is even higher when the intracellular cAMP concentration of follicular oocytes is increased by treatment with 8-Br-cAMP) (Fig. 4A) or hCG (Fig. 4C) .
This series of experiments suggests that low doses of cAMP "prime" the K+ channels in the membrane, so they can be opened more easily by Ck. Acetylcholine acting upon muscarinic receptors attenuates the IcAMP elicited by adrenaline, dopamine, adenosine, gonadotropins, vasoactive intestinal peptide, forskolin, prostaglandins, and intracellular injections of cAMP (20, 22, 27) . Muscarinic attenuation of K+ currents is mimicked by phorbol esters (27) , and both effects are mediated through activation of protein kinase C (27) . Fig. 4 (29) , and for vasodilators, such as vasoactive intestinal peptide, which increase cAMP (23) . It would then be expected that at least some of the conclusions of this paper may also hold for Ck-activated K+ channels in both smooth muscle cells and neurons. icked by KCO and blocked by sulfonylureas, these two categories of drugs might be expected to modulate growth and maturation and enlargement of the follicle as well as ovulation and meiotic division of the cell. 
